Financhill
Back

OncoCyte Vs. Repligen Industry Stock Comparison

Sell
36

OCX
OncoCyte

Last Price:
2.77
Seasonality Move:
-25.1%
Sell
40

RGEN
Repligen

Last Price:
124.23
Seasonality Move:
6.66%
Sell
36
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.76. The Score for OCX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.35. The Score for RGEN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.76
    The current trend is relatively stagnant and OCX is experiencing slight buying pressure.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 50.88 Buy
Chaikin Money Flow: 2150 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.68 - 2.88) Sell
Bollinger Bands (100): (2.69 - 3.03) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.73 Sell
Relative Strength Index (14 RSI): 20.87 Sell
Chaikin Money Flow: -821600 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (138.42 - 167.6) Sell
Bollinger Bands (100): (156.71 - 196.77) Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.75 Buy
20-day SMA: 2.74 Buy
50-day SMA: 2.73 Buy
200-day SMA: 3.01 Sell
8-day EMA: 2.74 Buy
20-day EMA: 2.75 Buy
50-day EMA: 2.78 Sell
200-day EMA: 3.58 Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 136.85 Sell
20-day SMA: 148.53 Sell
50-day SMA: 159.9 Sell
200-day SMA: 168.74 Sell
8-day EMA: 134.86 Sell
20-day EMA: 145.51 Sell
50-day EMA: 158.27 Sell
200-day EMA: 169.28 Sell

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.43 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.28 per share, and an increase next year of $0.56 per share.

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):